ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) ...
MPR9d
Iluvien Approved for Chronic Non-Infectious Posterior Uveitis
The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...
Morningstar14d
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin ...
ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...
manilatimes14d
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin marketing ...
Optometry Advisor9d
Microinvasive Glaucoma Surgeries Circumvent the Challenges of Other Therapies
Minimally invasive glaucoma surgeries offer an alternative to glaucoma drops, which, in some cases, do not adequately lower IOP and show poor compliance.
casereports.bmj7d
Ocular ischaemic syndrome due to giant cell arteritis
It may present with anterior segment ischaemia heralded by hypotony and corneal oedema ... Furthermore, in the absence of immunosuppression, visual loss in one eye confers a 50% risk of visual loss in ...
bjo.bmj17d
Changes in axial length following trabeculectomy and glaucoma drainage device surgery
The Doheny Eye Institute, Keck School of Medicine ... 10.2% (4/39) of trabeculectomy patients had hypotony after 3 months, with a mean AL reduction (−0.39 (0.11)) that was statistically significantly ...